` CMXC (Cell MedX Corp) vs S&P 500 Comparison - Alpha Spread

CMXC
vs
S&P 500

Over the past 12 months, CMXC has outperformed S&P 500, delivering a return of +17% compared to the S&P 500's +14% growth.

Stocks Performance
CMXC vs S&P 500

Loading
CMXC
S&P 500
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
CMXC vs S&P 500

Performance Gap Between CMXC and GSPC
HIDDEN
Show

Performance By Year
CMXC vs S&P 500

Loading
CMXC
S&P 500
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Cell MedX Corp vs Peers

No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Cell MedX Corp
Glance View

Market Cap
3.1m USD
Industry
Health Care

Cell MedX Corp. is a biotech company, which engages in the discovery, development and commercialization of therapeutic and non-therapeutic products that promote general wellness. The company is headquartered in Carson City, Nevada. The company went IPO on 2013-03-11. The Company, through its subsidiary, is engaged in developing and manufacturing therapeutic devices based on its proprietary eBalance technology, which harnesses the power of microcurrents and its effects on the human body. The Company’s eBalance Pro System and eBalance Home System, are microcurrent electrotherapy systems intended to administer a specific variety of therapeutic microcurrent algorithms for temporary relief of pain associated with sore/aching muscles in the shoulders, waist, back, neck, upper extremities (arms) and lower extremities (legs) due to strain from exercise or normal household- or work-related activities, as well as for general relaxation.

CMXC Intrinsic Value
Not Available
Back to Top